JZJingjing Zhou

Jingjing Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jingjing Zhou has a total of 167 co-authors. Here are the top co-authors by number of shared publications:

  • Gang Wang

    Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders; National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, China

    10 shared publications
  • Jing Liu

    Beijing Anding Hospital, Capital Medical University

    6 shared publications
  • Ruinan Li

    Beijing Anding Hospital, Capital Medical University

    6 shared publications
  • Xueshan Zhang

    Beijing Anding Hospital, Capital Medical University

    6 shared publications
  • Dan Li

    Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders; National Clinical Research Center for Mental Disorders; National Center for Mental Disorders; Beijing Anding Hospital, Capital Medical University, Beijing, China

    5 shared publications
  • Xiaoya Li

    Beijing Anding Hospital, Capital Medical University

    4 shared publications

Latest Publications

  • Open Access

    Stability of depressive and manic symptoms as a predictor of conversion from major depressive disorder to bipolar disorder: A prospective cohort study

    by Han Qi, Zizhao Feng, Yuan Feng, Le Xiao, Ruinan Li, Xiaoya Li, Jing Liu, Xueshan Zhang, Jingjing Zhou, Gang Wang

    Background: Bipolar disorder (BD) is characterized by mood fluctuations and is prone to misdiagnosis as major depressive disorder (MDD). Quantifying the relationship between symptom fluctuations and conversion risk is essential for early identification. Methods: In a national prospective cohort of patients with MDD (enrolled from May 2022 to February 2025), depressive and manic symptoms were assessed using clinician-rated and self-report instruments. Two measures were calculated: the time in target range (TTR), the proportion of numbers of evaluations with scores below predefined clinical cutoffs; and Statistical Process Control (SPC) stability, evaluated with a person-specific approach defining each individual’s normal fluctuation range via their 25th–75th percentiles. The outcome was the incidence of manic or hypomanic episodes that met the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition criteria. Cox regression models were used to evaluate the associations of the TTR and SPC with the conversion to BD. Results: Among the 2,367 eligible patients with MDD (mean [SD] age, 29.88 [9.79] years; 792 [33.46%] male), 69 (2.92%) converted to BD in the 52-week follow-up. During weeks 0-8, higher TTR of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16) (cutoff set at ≤10) and the 33-item Hypomania Checklist (HCL-33) (cutoffs set at ≤7 and ≤15) were significantly associated with a lower risk of conversion between Weeks 8 and 52. Additionally, a greater SPC-evaluated stability of the HCL-33 scores was significantly associated with lower conversion risk over the same period. Conclusions: While further validation in independent samples is still needed, continuous monitoring of hypomanic symptoms, especially evaluated with the HCL-33, may be of clinical significance for the early identification of conversion to BD.

  • Open Access

    Temporal interference stimulation for working memory deficits in schizophrenia: a pilot trial

    by Zongyu Zhang, Jingtao Chi, Qi Wang, Yunyi Han, Wenpeng Hou, Jingjing Zhou

  • Open Access

    Functional connectivity of anterior cingulate cortex subregions in suicidal ideation in major depression: circuit mechanisms, exploratory classification, and treatment-related changes

    by Yifan Jing, Lin Jing, Xiongying Chen, Jinjie Xu, Dan Li, Ruinan Li, Xiaoya Li, Jing Liu, Xueshan Zhang, Jingjing Zhou, et al.

    Suicidal ideation (SI) is a critical challenge in major depressive disorder (MDD), yet its precise neural circuitry remains elusive. Although anterior cingulate cortex (ACC) is implicated, its subregional roles remain poorly understood. This study aimed to delineate SI-specific neural circuitry by examining whole-brain functional connectivity (FC) of ACC subregions: subgenual ACC (sgACC), pregenual ACC (pgACC), and dorsal ACC (dACC). Resting-state functional magnetic resonance imaging data were analyzed from 237 MDD patients (109 with SI [MDD-SI], 128 without SI [MDD-NSI]) and 152 healthy controls (HCs) at baseline. Group assignment relied on lifetime SI (trait-like SI) from the Columbia-Suicide Severity Rating Scale, with current SI (state-like SI) measured by the suicide item of 17-item Hamilton Depression Rating Scale. Of these, 129 MDD patients underwent 8-week follow-up scanning after treatment. Cross-sectional analysis identified two SI-specific FC alterations: left pgACC-right precuneus and left dACC-left fusiform connectivity. These FCs were enhanced in MDD-SI compared to MDD-NSI, showed no differences between MDD-NSI and HCs, and correlated with trait-like SI severity. An exploratory model incorporating these FCs and clinical covariates achieved an area under the curve (AUC) of 0.723 for trait-like SI identification. Longitudinally, the baseline elevation in left pgACC-right precuneus FC normalized after treatment specifically in MDD-SI, and this reduction paralleled the decrease in state-like SI severity. Our findings clarify ACC subregion-specific SI mechanisms, provide an exploratory evaluation of trait-like SI identification and identify a potential state-like SI therapeutic circuit. Collectively, this work translates vague ACC abnormality into localizable circuits, advancing precision neuroscience for MDD-SI.

  • Efficacy and safety of adjunctive transcranial alternating current stimulation in bipolar depression: A randomized controlled trial

    by Jinjie Xu, Dan Li, Yafei Liu, Fukang Ye, Lin Jing, Yifan Jing, Xiaoya Li, Ruinan Li, Tong Zhu, Fan Yang, et al.

  • Top Cited Papers
    Open Access

    Adjunctive fecal microbiota transplantation for major depressive disorder: A randomized, double-blind, placebo-controlled trial

    by Jing Li, Yaping Wang, Ruinan Li, Huanwei Huang, Xuequan Zhu, Xiaozheng Li, Zuoli Sun, Ling Zhang, Peng Zheng, Yi He, et al.


  • Differential effects of individualized vs. fixed-frequency tACS on clinical and EEG outcomes in major depressive disorder

    by Dan Li, Jia Zhou, Zizhao Feng, Ruinan Li, Xiaoya Li, Jinjie Xu, Xueshan Zhang, Jing Liu, Yafei Liu, Amit Chopra, et al.


  • Open Access

    Distinct Trajectories of Amygdala Connectivity Patterns Characterize Remission vs. Non‐Remission in Patients With Major Depressive Disorder

    by Shudong Zhang, Zhifang Zhang, Xiaoya Li, Jingjing Zhou, Ruinan Li, Rui Liu, Yun Wang, Xiongying Chen, Yuan Feng, Jian Cui, et al.

    Background: This study aimed to investigate the neural basis of individual differences in antidepressant efficacy using an 8‐week longitudinal multitime point resting‐state functional magnetic resonance imaging (fMRI) design. Methods: Forty‐eight patients with major depressive disorder (MDD) completed two or three scans, and 44 healthy controls (HCs) underwent a baseline scan. Patients were categorized into remission (MDDr) and nonremission (MDDnr) groups based on treatment outcomes. Group differences in resting‐state functional connectivity (rsFC) of the amygdala subregions at baseline were examined among MDDr, MDDnr, and HCs. Longitudinal changes in the identified rsFC were compared between the MDDr and MDDnr groups. Correlation analyses were conducted to explore the relationship between baseline rsFC or its longitudinal changes and depressive symptom severity or improvement. Results: At baseline, rsFC between the right basolateral (BL) amygdala and the right supplementary motor area (SMA) was lower in the MDDr group but higher in the MDDnr group compared with HCs, although this effect did not survive multiple comparisons correction across amygdala subregions. The trajectory of this rsFC differed between the two patient groups during treatment, with normalization observed at 2 and 8 weeks posttreatment. Correlation analyses indicated that baseline rsFC was associated with treatment response and that longitudinal changes in rsFC were aligned with symptom improvement, although some associations did not survive multiple comparisons correction. Conclusions: Our findings provide novel and valuable insights into the neural mechanisms underlying antidepressant response and highlight the role of amygdala subregional connectivity in explaining interindividual variability in treatment efficacy. Trial Registration: ClinicalTrials.gov identifier: ChiCTR2400093823

  • Open Access

    Group-Based Trajectory Analysis of Depressive Symptoms in Patients Treated with Antidepressants in Chinese Cohort Studies

    by Jia Zhou, Xiao Wang, Lei Feng, Yuan Feng, Le Xiao, Xu Chen, Zizhao Feng, Gang Wang, Jingjing Zhou

    The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)

  • Open Access

    Interrelationships Among Personality Traits, Depressive Symptoms, Childhood Abuse, and Social Disability

    by Zizhao Feng, Jia Zhou, Rui Liu, Le Xiao, Yuan Feng, Ruinan Li, Xiaoya Li, Xueshan Zhang, Jing Liu, Gang Wang, et al.

    Background: Personality traits and childhood abuse were found to be associated with depressive symptoms and with each other. However, no previous study has elucidated the directional interrelationship among those factors in a clinical population of patients with major depressive disorder (MDD). This study sought to construct networks to explicate the directional interrelationship among those factors and social disability, identify the most central factor, and explore potentially existing causality chains implied by the directed association chains. Methods: This cross‐sectional study analyzed data from 1445 patients with MDD in a national cohort. Personality traits were measured using the Eysenck Personality Questionnaire‐Revised Short Scale for Chinese (EPQ‐RSC). Seven dimensions of depressive symptoms were measured with various scales: depression, anxiety, insomnia, and somatic symptoms with the 17‐item Hamilton Depression Rating Scale (HAMD‐17), the loss of pleasure sensation with the Snaith‐Hamilton Pleasure Scale (SHAPS), apathy with the Modified Apathy Evaluation Scale (MAES), and fatigue with the Chalder Fatigue Scale (CFS‐11). Childhood abuse experience was measured using the Childhood Trauma Questionnaire‐Short Form (CTQ‐SF). Social disability was measured with the Sheehan Disability Scale (SDS). Undirected and Bayesian network analyses were used to identify central factors and explore directional interrelationships among the variables. Results: The loss of pleasure sensation was the most central in terms of strength and closeness. In the directed acyclic graph (DAG) derived from the Bayesian network analysis, psychoticism was positioned at the highest level in the model, suggesting its causal precedence. One key directed association chain, which implied a potentially existing causality chain, was that psychoticism predicted the loss of pleasure sensation, and this symptom predicted social disability. Conclusion: Loss of pleasure sensation and psychoticism might be important for future research in MDD. The appearance of psychoticism at the beginning of the directed association chain (which implied a potentially existing causality chain) involving the central factor and the characteristics of high psychoticism implied that the social/interpersonal component of the loss of pleasure sensation may be a meaningful focus of future research and intervention of MDD. Trial Registration: Chinese Clinical Trial Registry: ChiCTR2200059053